SI3038654T1 - Nova uporaba - Google Patents

Nova uporaba

Info

Publication number: SI3038654T1
Authority: SI; Slovenia
Prior art keywords: new use; new
Prior art date: 2013-08-26

Application number

SI201431464T

Other languages

English (en)

Inventor

Victor Chengwei Shi

Martin Lefkowitz

Adel Remond Rizkala

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-08-26

Filing date

2014-08-26

Publication date

2020-02-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51494327&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI3038654(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-08-26 Priority claimed from PCT/US2013/056680 external-priority patent/WO2015030711A1/en

2014-08-26 Application filed by Novartis Ag filed Critical Novartis Ag

2020-02-28 Publication of SI3038654T1 publication Critical patent/SI3038654T1/sl

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

SI201431464T 2013-08-26 2014-08-26 Nova uporaba SI3038654T1 (sl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
PCT/US2013/056680 WO2015030711A1 (en)	2013-08-26	2013-08-26	New use
US201461972933P	2014-03-31	2014-03-31
EP14761702.1A EP3038654B1 (en)	2013-08-26	2014-08-26	New use
PCT/IB2014/064074 WO2015028941A1 (en)	2013-08-26	2014-08-26	New use

Publications (1)

Publication Number	Publication Date
SI3038654T1 true SI3038654T1 (sl)	2020-02-28

Family

ID=51494327

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SI201431464T SI3038654T1 (sl)	2013-08-26	2014-08-26	Nova uporaba
SI201432059T SI3626270T1 (sl)	2013-08-26	2014-08-26	Zdravljenje srčno-žilnih bolezni

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SI201432059T SI3626270T1 (sl)	2013-08-26	2014-08-26	Zdravljenje srčno-žilnih bolezni

Country Status (15)

Country	Link
US (2)	US20160213646A1 (sl)
EP (3)	EP3626270B1 (sl)
JP (1)	JP6097888B2 (sl)
CY (1)	CY1122531T1 (sl)
DK (2)	DK3626270T3 (sl)
ES (2)	ES2767084T3 (sl)
FI (1)	FI3626270T3 (sl)
HR (2)	HRP20240034T1 (sl)
HU (2)	HUE064634T2 (sl)
LT (2)	LT3038654T (sl)
PL (2)	PL3038654T3 (sl)
PT (2)	PT3038654T (sl)
RS (2)	RS59816B1 (sl)
SI (2)	SI3038654T1 (sl)
WO (1)	WO2015028941A1 (sl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US10562866B2 (en) *	2015-02-06	2020-02-18	Mylan Laboratories Limited	Amorphous trisodium sacubitril valsartan and a process for the preparation thereof
JP2018516267A (ja) *	2015-05-29	2018-06-21	ノバルティスアーゲー	代謝性疾患を治療するためのサクビトリルおよびバルサルタン
CN106309388A (zh) *	2015-06-30	2017-01-11	深圳信立泰药业股份有限公司	一种用于心衰治疗的药物组合物及其制备方法
CN107510653A (zh) *	2016-06-17	2017-12-26	常州爱诺新睿医药技术有限公司	一种含有无定型沙库比曲和缬沙坦的固体分散体的药用组合物及其制备方法
WO2017036420A1 (zh) *	2015-09-06	2017-03-09	常州方楠医药技术有限公司	含沙库比曲和缬沙坦的药用组合物及其制备方法
CN106491600A (zh) *	2015-09-06	2017-03-15	常州方楠医药技术有限公司	无定型沙库区比、缬沙坦或其药学上可接受的盐与药用辅料的组合物及其制备方法
WO2017042700A1 (en) *	2015-09-07	2017-03-16	Sun Pharmaceutical Industries Limited	Solid forms of valsartan and sacubitril
US20180303799A1 (en) *	2015-10-16	2018-10-25	Shenzhen Salubris Pharmaceuticals Co., Ltd	An Oral Preparation for the Treatment of Cardiovascular Disease and Its Preparation Method
CN105330609B (zh) *	2015-12-07	2017-12-22	南京正大天晴制药有限公司	一种制备lcz696的方法
CN108601741B (zh) *	2016-02-03	2022-05-24	诺华股份有限公司	有机化合物的盖伦制剂
CN106176681A (zh) *	2016-08-25	2016-12-07	泰力特医药（湖北）有限公司	一种抗心脏衰竭药物lcz696口服缓释微丸及其制备方法
US11382866B2 (en)	2017-07-06	2022-07-12	Mankind Pharma Ltd.	Fixed dose pharmaceutical composition of valsartan and sacubitril
CA3110152A1 (en)	2018-08-23	2020-02-27	Novartis Ag	New pharmaceutical use for the treatment of heart failure
WO2020039394A1 (en)	2018-08-24	2020-02-27	Novartis Ag	New drug combinations
TWI809313B (zh) *	2019-09-20	2023-07-21	大陸商深圳信立泰藥業股份有限公司	血管緊張素ii受體拮抗劑代謝產物與nep抑制劑的複合物的新心衰用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19675036I2 (de)	1990-02-19	2004-10-21	Novartis Ag	Acylverbindungen.
US5217996A (en)	1992-01-22	1993-06-08	Ciba-Geigy Corporation	Biaryl substituted 4-amino-butyric acid amides
KR20000070046A (ko) *	1997-01-10	2000-11-25	폴락 돈나 엘.	심부전증을 치료하기 위한, 안지오텐신 ⅱ 길항제를 포함하는 약제학적 조성물
SI1467728T1 (sl)	2002-01-17	2008-02-29	Novartis Ag	Farmacevtski sestavki vkljucujoci valsartan in NEP inhibitorje
WO2004101535A1 (en) *	2003-05-16	2004-11-25	Novartis Ag	Pharmaceutical composition comprising valsartan
AR057882A1 (es)	2005-11-09	2007-12-26	Novartis Ag	Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra
HRP20230178T3 (hr)	2007-11-06	2023-03-31	Novartis Ag	Farmaceutski pripravci temeljeni na nadgradnjama antagonista/blokatora angiotenzinskog receptora (arb) i inhibitoru neutralne endopeptidaze (nep)
EP2361085B9 (en)	2008-11-22	2019-01-02	F.Hoffmann-La Roche Ag	Use of anti-vegf antibody in combination with chemotherapy for treating breast cancer
US20130158088A1 (en)	2010-08-24	2013-06-20	Novartis Ag	Treatment of hypertension and/or prevention or treatment of heart failure in a mammal receiving anti-coagulant therapy
KR20200111822A (ko)	2012-08-24	2020-09-29	노파르티스 아게	심방 확장 또는 재형성을 특징으로 하는 질환을 치료하기 위한 nep 억제제
JP2016530282A (ja) *	2013-08-26	2016-09-29	ノバルティスアーゲー	新規使用

2014
- 2014-08-26 SI SI201431464T patent/SI3038654T1/sl unknown
- 2014-08-26 DK DK19202854.6T patent/DK3626270T3/da active
- 2014-08-26 HR HRP20240034TT patent/HRP20240034T1/hr unknown
- 2014-08-26 LT LTEP14761702.1T patent/LT3038654T/lt unknown
- 2014-08-26 EP EP19202854.6A patent/EP3626270B1/en active Active
- 2014-08-26 HU HUE19202854A patent/HUE064634T2/hu unknown
- 2014-08-26 EP EP23202190.7A patent/EP4321157A3/en active Pending
- 2014-08-26 RS RS20200047A patent/RS59816B1/sr unknown
- 2014-08-26 SI SI201432059T patent/SI3626270T1/sl unknown
- 2014-08-26 RS RS20240031A patent/RS65037B1/sr unknown
- 2014-08-26 WO PCT/IB2014/064074 patent/WO2015028941A1/en active Application Filing
- 2014-08-26 PT PT147617021T patent/PT3038654T/pt unknown
- 2014-08-26 PL PL14761702T patent/PL3038654T3/pl unknown
- 2014-08-26 PT PT192028546T patent/PT3626270T/pt unknown
- 2014-08-26 LT LTEP19202854.6T patent/LT3626270T/lt unknown
- 2014-08-26 ES ES14761702T patent/ES2767084T3/es active Active
- 2014-08-26 EP EP14761702.1A patent/EP3038654B1/en active Active
- 2014-08-26 FI FIEP19202854.6T patent/FI3626270T3/fi active
- 2014-08-26 PL PL19202854.6T patent/PL3626270T3/pl unknown
- 2014-08-26 DK DK14761702.1T patent/DK3038654T3/da active
- 2014-08-26 HU HUE14761702A patent/HUE047186T2/hu unknown
- 2014-08-26 ES ES19202854T patent/ES2968541T3/es active Active
- 2014-08-26 US US14/914,005 patent/US20160213646A1/en not_active Abandoned
- 2014-08-26 JP JP2016537414A patent/JP6097888B2/ja active Active
2020
- 2020-01-16 HR HRP20200060TT patent/HRP20200060T1/hr unknown
- 2020-01-28 CY CY20201100075T patent/CY1122531T1/el unknown
- 2020-11-24 US US17/103,327 patent/US20210077461A1/en active Pending

Also Published As

Publication number	Publication date
EP3626270B1 (en)	2023-10-11
EP3038654A1 (en)	2016-07-06
DK3038654T3 (da)	2020-02-03
EP4321157A2 (en)	2024-02-14
RS65037B1 (sr)	2024-02-29
PT3038654T (pt)	2020-02-04
EP3038654B1 (en)	2019-10-30
ES2767084T3 (es)	2020-06-16
US20160213646A1 (en)	2016-07-28
EP3626270A1 (en)	2020-03-25
HUE047186T2 (hu)	2020-04-28
DK3626270T3 (da)	2024-01-15
HRP20240034T1 (hr)	2024-03-29
PT3626270T (pt)	2024-01-11
CY1122531T1 (el)	2021-01-27
JP2016528303A (ja)	2016-09-15
EP4321157A3 (en)	2024-05-15
PL3038654T3 (pl)	2020-05-18
WO2015028941A1 (en)	2015-03-05
FI3626270T3 (fi)	2024-01-11
US20210077461A1 (en)	2021-03-18
LT3626270T (lt)	2024-01-25
JP6097888B2 (ja)	2017-03-15
PL3626270T3 (pl)	2024-04-08
RS59816B1 (sr)	2020-02-28
HUE064634T2 (hu)	2024-04-28
HRP20200060T1 (hr)	2020-04-03
LT3038654T (lt)	2020-01-27
ES2968541T3 (es)	2024-05-10
SI3626270T1 (sl)	2024-03-29

Publication	Publication Date	Title
SI2994467T1 (sl)	2018-12-31	Arilkinazolini
PL3038654T3 (pl)	2020-05-18	Nowe zastosowanie
GB201305825D0 (en)	2013-05-15	New use
HK1204451A1 (en)	2015-11-20	Novel use
AU353575S (en)	2014-02-07	Stamphousing
LU92283B1 (en)	2015-03-24	Noseclip
GB201322271D0 (en)	2014-01-29	Lasanordning
GB201421602D0 (en)	2015-01-21	Zielfernrohr
GB201321218D0 (en)	2014-01-15	Novel use
GB201321223D0 (en)	2014-01-15	Novel use
GB201319828D0 (en)	2013-12-25	Novel use
GB201319824D0 (en)	2013-12-25	Novel use
GB201318415D0 (en)	2013-12-04	Novel use
GB201318414D0 (en)	2013-12-04	Novel use
GB201320265D0 (en)	2014-01-01	GreetGate
AU353329S (en)	2014-01-21	Kettlebell
AU353328S (en)	2014-01-21	Kettlebell
AU353327S (en)	2014-01-21	Kettlebell
AU353331S (en)	2014-01-21	Kettlebell
AU353325S (en)	2014-01-21	Kettlebell
AU353330S (en)	2014-01-21	Kettlebell
GB201319794D0 (en)	2013-12-25	Drawcode
AU353326S (en)	2014-01-21	Kettlebell
GB201319426D0 (en)	2013-12-18	Snagpro
GB201318627D0 (en)	2013-12-04	Laddfix